Use of prostaglandin E2 in the management of intra-uterine death.
D000650:Amnion; D004958:Estradiol / Q000097:blood; D005260:Female; D005313:Fetal Death / Q000097:blood / Q000628:therapy*; D006801:Humans; D007267:Injections; D007751:Labor, Induced; D007744:Obstetric Labor Complications / Q000453:epidemiology; D010922:Placenta Diseases / Q000150:complications; D010928:Placental Lactogen / Q000097:blood; D011247:Pregnancy; D011374:Progesterone / Q000097:blood; D011453:Prostaglandins / Q000008:administration & dosage* / Q000009:adverse effects; D011863:Radioimmunoassay; D011869:Radioligand Assay
D011453:Prostaglandins; D011374:Progesterone; D004958:Estradiol; D010928:Placental Lactogen